文献速递系统性红斑狼疮其他结缔组织病

筛查用酶免疫分析法与间接免疫荧光法检测系统性风湿病患者抗核抗体的诊断价值:系统评价与荟萃分析

Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
PubMed 文献 · Semin Arthritis Rheum · 2018-03-31

该系统评价与荟萃分析检索截至2017年8月的文献,纳入33项研究,比较筛查用酶免疫分析法(SEIA)与间接免疫荧光法(IIF)检测系统性风湿病(SRD)患者抗核抗体(ANA)的诊断准确性。合并结果显示,IIF在SLE患者中敏感性高于SEIA且差异有统计学意义,两者特异性与标准化方面相当。

要点

  • 合并SRD中SEIA与IIF敏感性分别为87.4%与88.4%,特异性分别为79.7%与78.9%。
  • SLE患者中IIF敏感性95.2%高于SEIA的89.4%,差异有统计学意义。
  • SSc患者中IIF敏感性93.6%高于SEIA的85.4%,特异性SEIA 92.8%高于IIF 84.2%。

核心结论

  • SEIA与IIF均可用于检测SRD患者的ANA。
  • IIF是比SEIA更敏感的筛查方法,尤其在SLE患者中。
  • 考虑特异性与标准化时,SEIA与IIF相当。

研究设计与样本

  • 系统检索Medline、Embase、Cochrane、Web of Science和Scopus数据库中2017年8月前发表的文章。
  • 采用双变量随机效应模型计算合并诊断价值。
  • 纳入33项研究,包括合并SRD患者3976例、SLE患者2839例、SS患者610例、SSc患者1002例,以及非健康对照11716例和健康对照8408例。

主要发现

  • 合并SRD中SEIA与IIF的合并敏感性分别为87.4%与88.4%,合并特异性分别为79.7%与78.9%。
  • SLE患者中SEIA与IIF的合并敏感性分别为89.4%与95.2%,合并特异性分别为89.1%与83.3%。
  • SS患者中SEIA与IIF的合并敏感性分别为88.7%与88.4%,合并特异性分别为89.9%与86.8%。
  • SSc患者中SEIA与IIF的合并敏感性分别为85.4%与93.6%,合并特异性分别为92.8%与84.2%。
  • 大多数亚组中SEIA与IIF的敏感性和特异性差异无统计学意义,但SLE的合并敏感性呈现有统计学意义的变化。

关键数值与推荐

  • 合并SRD中SEIA敏感性87.4% vs IIF 88.4%,特异性SEIA 79.7% vs IIF 78.9%。
  • SLE中SEIA敏感性89.4% vs IIF 95.2%,特异性SEIA 89.1% vs IIF 83.3%。
  • SS中SEIA敏感性88.7% vs IIF 88.4%,特异性SEIA 89.9% vs IIF 86.8%。
  • SSc中SEIA敏感性85.4% vs IIF 93.6%,特异性SEIA 92.8% vs IIF 84.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to review and compare the diagnostic accuracy of the screening enzyme immunoassay (SEIA) and indirect immunofluorescence (IIF) as anti-nuclear antibody (ANA) screening assays for patients with systemic rheumatic diseases (SRDs), including systemic lupus erythematosus (SLE), Sjögren's syndrome (SS), and systemic sclerosis (SSc). METHODS: A systematic literature search was conducted in the Medline, Embase, Cochrane, Web of Science, and Scopus databases for articles published before August 2017. A bivariate random effects model was used to calculate pooled diagnostic values. RESULTS: Thirty-three studies including 3976 combined SRDs, 2839 SLE, 610 SS, and 1002 SSc patients and 11,716 non-healthy and 8408 healthy controls were available for the meta-analysis. The summary sensitivities of SEIA vs. IIF were 87.4% vs 88.4% for combined SRDs, 89.4% vs. 95.2% for SLE, 88.7% vs. 88.4% for SS, and 85.4% vs. 93.6% for SSc, respectively. Meanwhile, the summary specificities of SEIA vs. IIF were 79.7% vs.78.9% for combined SRDs, 89.1% vs. 83.3% for SLE, 89.9% vs. 86.8% for SS, and 92.8% vs. 84.2% for SSc, respectively. Although the differences in sensitivity and specificity between SEIA and IIF were not significant in most subgroups, the summary sensitivity of SLE presented statistically significant changes. CONCLUSIONS: Our systematic meta-analysis demonstrates that both SEIA and IIF are useful to detect ANAs for SRDs. Between the two assays, IIF is a more sensitive screening assay than SEIA, particularly in patients with SLE. SEIA is comparable to IIF, considering the specificity and standardization.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Jeong S, Yang D, Lee W, et al. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018. PMID: 29609799. doi:10.1016/j.semarthrit.2018.01.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。